Patent classifications
C
CHEMISTRY; METALLURGY
Load children
C12
BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
Load children
C12N
MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
Load children
C12N2770/28033
Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
Filter patents View analytics View as hierarchy Open in page

C12N2770/28033

Compositions and methods for antigen targeting to CD180
11549102 · 2023-01-10 · ·

The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

Compositions and Methods for Antigen Targeting to CD180
20230113073 · 2023-04-13 ·

The present invention provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

Compositions and Methods for Antigen Targeting to CD180
20200216819 · 2020-07-09 ·

The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

Compositions and methods for antigen targeting to CD180
12018291 · 2024-06-25 · ·

The present invention provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

Compositions and Methods for Antigen Targeting to CD180
20190144834 · 2019-05-16 ·

The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

Compositions and Methods for Antigen Targeting to CD180
20240301364 · 2024-09-12 ·

The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

Compositions and methods for antigen targeting to CD180
12371672 · 2025-07-29 · ·

The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.